CT-996
CT-996 is an orally active GLP-1RA agonist, with an EC50 of 0.49 nM. CT-996 reduces the β-arrestin recruitment and GLP-1R internalization. CT-996 suppresses postprandial blood glucose following a mixed meal tolerance test (MMTT) in mice expressing the human GLP-1 receptor and enhances glucose stimulated insulin secretion (GSIS) during an intravenous glucose challenge in obese monkeys. CT-996 can be used for the study of type 2 diabetes (T2D) and obesity[1][2].
Product Specifications
CAS Number
2810808-95-6
Product Name Alternative
RO7795081; RG6652
UNSPSC
12352100
Target
Arrestin; GLP Receptor
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Purity
99.97
Solubility
DMSO : ≥ 100 mg/mL
Smiles
C[C@@H](C[C@H](CC1)OC2=NC(COC3=C(C=C(C=C3)F)F)=NC=C2)N1CC(N(C4=C5)C[C@@H]6CCO6)=NC4=CC=C5C(O)=O
Molecular Formula
C30H31F2N5O5
Molecular Weight
579.59
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Dnmt1, phosphorylated (S1105) (DNMT1, AIM, CXXC9, DNMT, DNA (cytosine-5) -methyltransferase 1, CXXC-type zinc finger protein 9, DNA methyltransferase HsaI, MCMT) (MaxLight 405) discontinued
Camkv, NT (Camkv, CaM kinase-like vesicle-associated protein) (MaxLight 405) discontinued